P-293 Overall survival according to mutation frequency of BRAF, NRAS genes, and MSI status in patients with wild-type KRAS metastatic colorectal cancer treated with cetuximab
Santos, F., Reis, R., Barroti, L., Datorre, J., Pereira, A., Carvalho, A., Berardinelli, G., Araujo, R.Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.04.375
Date:
July, 2020
File:
PDF, 78 KB
2020